Literature DB >> 21693308

CXCR1 deficiency does not alter liver regeneration after partial hepatectomy in mice.

N Sakai1, S Kuboki, H L Van Sweringen, A D Tevar, R Schuster, J Blanchard, M J Edwards, A B Lentsch.   

Abstract

Previous studies have shown that CXC chemokines containing Glu-Leu-Arg (ELR) in their amino-terminus stimulate hepatocyte proliferation and liver regeneration after partial hepatectomy. These ELR+CXC chemokines bind to two receptors, CXCR1 and CXCR2. Previous work has shown that CXCR2 is involved in the proliferative effects of CXC chemokines. However, the function of CXCR1 during the regenerative response has not been studied. The aim of the current study was to investigate the role of CXCR1 in liver regeneration after partial hepatectomy. C57BL/6 (wild type) or CXCR1-/- mice were subjected to 70% partial hepatectomy or sham surgery and sacrificed on day 2 and 4 after operation. There were no significant differences in liver-to-body weight ratio or hepatocyte proliferation. The data suggest that CXCR1 does not mediate the proliferative effects of ELR+ CXC chemokines during liver regeneration after partial hepatectomy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21693308      PMCID: PMC3121003          DOI: 10.1016/j.transproceed.2011.03.028

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

Review 1.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

2.  A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice.

Authors:  Claudia Mitchell; Holger Willenbring
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury.

Authors:  Callisia Clarke; Satoshi Kuboki; Nozomu Sakai; Kevin R Kasten; Amit D Tevar; Rebecca Schuster; John Blanchard; Charles C Caldwell; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2010-12-07       Impact factor: 17.425

4.  Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC.

Authors:  A B Lentsch; H Yoshidome; W G Cheadle; F N Miller; M J Edwards
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

Review 5.  CXC chemokines play a critical role in liver injury, recovery, and regeneration.

Authors:  Callisia N Clarke; Satoshi Kuboki; Amit Tevar; Alex B Lentsch; Michael Edwards
Journal:  Am J Surg       Date:  2009-09       Impact factor: 2.565

6.  Interleukin-8 is essential for normal urothelial cell survival.

Authors:  Stephanie Tseng-Rogenski; Monica Liebert
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

7.  Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse.

Authors:  Xiaodan Ren; Audra Carpenter; Cory Hogaboam; Lisa Colletti
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.

Authors:  I Clark-Lewis; B Dewald; T Geiser; B Moser; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo.

Authors:  L M Colletti; M Green; M D Burdick; S L Kunkel; R M Strieter
Journal:  Shock       Date:  1998-10       Impact factor: 3.454

10.  Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Authors:  Michelle L Varney; Aihua Li; Bhavana J Dave; Corazan D Bucana; Sonny L Johansson; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

  10 in total
  5 in total

1.  The role of chemokines in acute liver injury.

Authors:  Yedidya Saiman; Scott L Friedman
Journal:  Front Physiol       Date:  2012-06-20       Impact factor: 4.566

2.  CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration.

Authors:  Gregory C Wilson; Satoshi Kuboki; Christopher M Freeman; Hiroyuki Nojima; Rebecca M Schuster; Michael J Edwards; Alex B Lentsch
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

3.  NRAS destines tumor cells to the lungs.

Authors:  Anastasios D Giannou; Antonia Marazioti; Nikolaos I Kanellakis; Ioanna Giopanou; Ioannis Lilis; Dimitra E Zazara; Giannoula Ntaliarda; Danai Kati; Vasileios Armenis; Georgia A Giotopoulou; Anthi C Krontira; Marina Lianou; Theodora Agalioti; Malamati Vreka; Maria Papageorgopoulou; Sotirios Fouzas; Dimitrios Kardamakis; Ioannis Psallidas; Magda Spella; Georgios T Stathopoulos
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

4.  Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion.

Authors:  Antonia Marazioti; Ioannis Lilis; Malamati Vreka; Hara Apostolopoulou; Argyro Kalogeropoulou; Ioanna Giopanou; Georgia A Giotopoulou; Anthi C Krontira; Marianthi Iliopoulou; Nikolaos I Kanellakis; Theodora Agalioti; Anastasios D Giannou; Celestial Jones-Paris; Yoichiro Iwakura; Dimitrios Kardamakis; Timothy S Blackwell; Stavros Taraviras; Magda Spella; Georgios T Stathopoulos
Journal:  Nat Commun       Date:  2018-02-14       Impact factor: 14.919

Review 5.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.